Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.64%13.5B | 4.37%3.39B | 2.58%3.45B | 4.34%3.34B | 3.30%3.32B | 9.17%13.03B | 9.01%3.25B | 9.19%3.36B | 7.73%3.2B | 10.79%3.21B |
Cost of revenue | 4.04%10.53B | 5.29%2.65B | 3.33%2.72B | 2.99%2.58B | 4.57%2.59B | 6.04%10.12B | 4.42%2.52B | 7.74%2.63B | 5.56%2.5B | 6.41%2.47B |
Gross profit | 2.26%2.98B | 1.22%740.41M | -0.09%733.97M | 9.17%767.31M | -0.95%733.98M | 21.69%2.91B | 28.44%731.48M | 14.73%734.65M | 16.24%702.87M | 28.45%741M |
Operating expense | 3.62%1.21B | 0.07%285.59M | -0.22%318.88M | 7.22%280.86M | 7.89%327.5M | 6.04%1.17B | 7.22%285.39M | 7.45%319.6M | 2.19%261.95M | 6.94%303.55M |
Operating profit | 1.34%1.76B | 1.96%454.82M | 0.01%415.08M | 10.33%486.45M | -7.08%406.49M | 35.10%1.74B | 47.05%446.09M | 21.06%415.05M | 26.59%440.92M | 49.29%437.45M |
Net non-operating interest income (expenses) | 22.89%-10.65M | 23.31%-2.46M | 22.88%-2.53M | 24.32%-2.65M | 21.25%-3.01M | 19.83%-13.81M | 17.44%-3.21M | 25.13%-3.28M | 22.33%-3.5M | 14.15%-3.82M |
Non-operating interest income | -81.37%120K | -68.27%33K | -84.42%24K | -83.82%39K | -83.45%24K | 6.98%644K | -48.77%104K | 21.26%154K | 73.38%241K | 9.02%145K |
Non-operating interest expense | -25.50%10.77M | -24.72%2.49M | -25.63%2.56M | -28.16%2.69M | -23.52%3.03M | -18.92%14.45M | -19.00%3.31M | -23.83%3.44M | -19.47%3.74M | -13.47%3.96M |
Net investment income | 18.96%15.68M | 14.29%3.22M | 29.14%4.85M | 9.77%4.08M | 22.07%3.53M | 21.40%13.18M | 77.76%2.81M | 15.33%3.75M | 7.59%3.72M | 12.91%2.9M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 157.82%97.7M | 105.92%20.79M | 360.72%36.69M | 47.99%22.34M | 277.30%17.88M | 307.92%37.9M | 668.15%10.1M | 56.69%7.96M | 300.66%15.1M | 113.80%4.74M |
Less:Other special charges | -157.82%-97.7M | -105.92%-20.79M | -360.72%-36.69M | -47.99%-22.34M | -277.30%-17.88M | -307.92%-37.9M | -668.15%-10.1M | -56.69%-7.96M | -300.66%-15.1M | -113.80%-4.74M |
Other non-operating income (expenses) | 0.88%18.29M | -3.73%8.75M | 11.41%2.94M | -37.09%2.19M | 51.08%4.41M | 13.40%18.13M | 128.23%9.09M | -47.56%2.64M | -18.51%3.49M | 8.20%2.92M |
Income before tax | 4.96%1.88B | 4.35%485.12M | 7.25%457.03M | 11.46%512.41M | -3.35%429.31M | 38.41%1.79B | 52.31%464.88M | 25.23%426.12M | 29.38%459.72M | 50.04%444.18M |
Income tax | 11.89%598.02M | 40.60%142.68M | 7.30%147M | 10.94%165M | -2.67%143.34M | 26.10%534.47M | -1.34%101.48M | 27.36%136.99M | 30.99%148.73M | 47.46%147.27M |
Net income | 2.02%1.29B | -5.77%342.44M | 7.23%310.03M | 11.71%347.41M | -3.68%285.97M | 44.38%1.26B | 79.58%363.4M | 24.25%289.13M | 28.63%310.99M | 51.35%296.91M |
Net income continuous operations | 2.02%1.29B | -5.77%342.44M | 7.23%310.03M | 11.71%347.41M | -3.68%285.97M | 44.38%1.26B | 79.58%363.4M | 24.25%289.13M | 28.63%310.99M | 51.35%296.91M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 2.02%1.29B | -5.77%342.44M | 7.23%310.03M | 11.71%347.41M | -3.68%285.97M | 44.38%1.26B | 79.58%363.4M | 24.25%289.13M | 28.63%310.99M | 51.35%296.91M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 2.02%1.29B | -5.77%342.44M | 7.23%310.03M | 11.71%347.41M | -3.68%285.97M | 44.38%1.26B | 79.58%363.4M | 24.25%289.13M | 28.63%310.99M | 51.35%296.91M |
Gross dividend payment | ||||||||||
Basic earnings per share | 2.03%81.02 | -5.72%21.58 | 7.19%19.53 | 11.74%21.89 | -3.69%18.02 | 44.38%79.41 | 79.67%22.89 | 24.20%18.22 | 28.63%19.59 | 51.38%18.71 |
Diluted earnings per share | 2.03%81.02 | -5.74%21.5758 | 7.21%19.53 | 11.74%21.8891 | -3.69%18.02 | 44.38%79.41 | 79.67%22.89 | 24.25%18.2168 | 28.63%19.59 | 51.38%18.71 |
Dividend per share | 4.35%24 | 4.35%24 | 0 | 0 | 0 | 53.33%23 | 53.33%23 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |